Loading...

Urban Demand And Renewable Energy Will Drive Future Healthcare Expansion

Published
26 Feb 25
Updated
05 Sep 25
AnalystConsensusTarget's Fair Value
₹1,754.80
13.9% undervalued intrinsic discount
05 Sep
₹1,510.40
Loading
1Y
8.9%
7D
3.6%

Author's Valuation

₹1.75k

13.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on05 Sep 25

With both the Future P/E ratio (rising marginally from 54.23x to 55.03x) and Net Profit Margin (steady at 14.84%) showing minimal movement, analyst consensus sees little fundamental change, leaving the fair value estimate unchanged at ₹1755. What's in the News Board meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2025.

Shared on01 May 25
Fair value Decreased 2.94%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 4.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.86%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 0.87%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.